eess.ASNov 15, 2026

Clinician Assessment of Laryngeal Disease with Auditory AI before Laryngoscopy: A Paired Reader Study

Authors: Siyuan Hou, Shuting Yang, Zengrui Jin, Liyu Cheng, Siyin Wang, Yunhan Shi, Xueyan Li, Rong Hu, 

Organizations: Department of Electronic Engineering, Tsinghua University, Beijing, 100084, China. · Department of Otorhinolaryngology Head and Neck Surgery, Beijing Tongren Hospital, Capital Medical University, Beijing, 100730, China. · Shanghai Artificial Intelligence Laboratory, Shanghai, 200030, China. · Yuquan Hospital, School of Clinical Medicine, Tsinghua Medicine, Tsinghua University, Beijing, 100040, China. · 

Abstract

Background: Before laryngoscopy, clinicians assess the likely cause of hoarseness and whether to suspect a precancerous or malignant lesion. Whether voice-based artificial intelligence (AI) supports pre-laryngoscopic categorization is unknown. Methods: We developed an auditory large language model that generates a patient-level assessment card (provisional category, voice-quality ratings, and rationale) and a prespecified malignancy alert from voice recordings, patient information, and acoustic measures obtained before laryngoscopy at one center. We evaluated both in a held-out test set and a later cohort. In a sequential reader study, 32 otolaryngology clinicians categorized held-out cases without AI and, 1 to 2 weeks later, reviewed their initial categories with the card (without the alert). Results: Across 800 paired assessments, reader accuracy was 49.8% before and 56.8% after review (difference, 7.0 percentage points; 95% CI, 1.7 to 13.5; P < 0.001); 99 categories changed from incorrect to correct and 43 from correct to incorrect (ratio, 2.30; 95% CI, 1.22 to 5.31). Accuracy rose 14.7 points when the model was correct and fell 8.7 when incorrect. Provisional-category accuracy was 72% in held-out testing and 67% in temporal validation. The malignancy alert flagged 85.7% and 86.8% of precancerous or malignant lesions. Sensitivity for precancerous or malignant lesions increased from 53.9% to 75.0% after AI-assisted review (difference, 21.1 percentage points; 95% CI, 4.3 to 42.0). Conclusions: In this single-center study, clinicians' pre-laryngoscopic categorization accuracy was higher after reviewing the AI assessment card, although the sequential design cannot fully separate AI assistance from reassessment; gains depended on model correctness without clearly selective adoption. Randomized and external evaluations, including of the malignancy alert, are needed.

Figures & tables

Explore similar work

Jul 20, 2026

Medical Imaging Fusing Vision Transformer: Laryngeal Cancer Screening with Explanation

Early and timely screening of laryngeal cancer is crucial for improving clinical outcomes. In recent years, NBI endoscopy has become a standard diagnostic tool for the detection of laryngeal lesions. However, its effective use requires well-trained clinicians and the procedure is time-consuming and subject to interobserver variability. In this context, the application of artificial intelligence (AI) offers a promising solution to support clinical decision-making. In this work, we proposed applying transformer and attention mechanism for analyzing the narrow band imaging and distinguish benign and malignant lesions. Results show it has good classification performance with F1 (82.72%), accuracy(82.33%). In addition, the result of laryngeal cancer screening is explainable for clinicians. The explainability is utilizing the state of art segmentation method (MedSAM) to provide the useful pathological information area for clinicians. The proposed methodology fusing classification and segmentation provides a translating on laryngeal cancer screening.
Oct 13, 2025

Benchmarking Deep Learning Models for Laryngeal Cancer Staging Using the LaryngealCT Dataset

Laryngeal cancer imaging research lacks standardised public datasets to enable reproducible deep learning (DL) model development. We present LaryngealCT, a curated benchmark of 1,029 computed tomography (CT) scans aggregated from six collections from The Cancer Imaging Archive (TCIA). Uniform 1 mm isotropic volumes of interest encompassing the larynx were extracted using a weakly supervised parameter search framework validated by clinical experts. Six 3D DL architectures (custom 3D CNN, ResNet18,50,101, DenseNet121 and MedicalNet-pretrained ResNet50) were benchmarked on (i) early (Tis,T1,T2) vs. advanced (T3,T4) and (ii) T4 vs. non-T4 classification tasks. On the independent test set, the 3D CNN achieved the strongest overall performance across global and per-class metrics (Accuracy 0.854, F1-macro 0.841) in early vs. advanced classification. In the T4 task, AU-ROC values exceeded 0.82 for most models, but sensitivity for T4 disease remained limited (less than or equal to 0.412), with ResNet101 showing the most promising calibrated T4 recall (0.706. Model explainability assessed using GradCAMpp with thyroid cartilage overlays for T4 classification task revealed anatomically plausible peri-cartilage activations, although spatial overlap was modest. Through open-source data, pretrained models, and integrated explainability tools, LaryngealCT offers a reproducible foundation for AI-driven research to support future clinical decision-making in laryngeal oncology.
Mar 15, 2026

Patient-level validation of a foundation-model pipeline for pediatric lung sounds: physician-annotated adventitious events are recognized, disease groups are not reliably predicted

Background: Lung-sound classifiers are usually evaluated on recording- or event-level splits, although each child contributes many recordings. We evaluated a foundation-model pipeline (PulmoVec) with the patient as the unit of partitioning and asked whether disease group can be predicted beyond age and sex. Methods: We analyzed 19693 physician-annotated respiratory events from 736 children in the public SPRSound database. A frozen Health Acoustic Representations (HeAR) encoder with low-rank adapters was trained for screening (normal versus adventitious), sound pattern (normal, crackles, wheeze/rhonchi) and disease group (pneumonia, bronchial disease, normal/other); event probabilities were stacked with age, sex and auscultation site. The primary analysis was nested patient-grouped cross-validation; comparators were the majority class, annotated event duration and demographics. Results: The area under the receiver operating characteristic curve (AUC) was 0.95 (95% CI 0.94 to 0.96) for both screening and sound pattern, against 0.78 and 0.75 for event duration alone; the positive predictive value for adventitious events was 0.72. Disease-group prediction reached an AUC of 0.58 (95% CI 0.54 to 0.62), and its accuracy was below the majority-class rate at event level (0.44 versus 0.62) and at patient level (0.46 versus 0.60). Conclusions: Recognition of physician-annotated adventitious events holds under patient-level validation and is not explained by event duration or demographics, although its positive predictive value would limit unaided use. Prediction of disease group, a clinical diagnosis, from lung-sound events alone was not demonstrated. Lung-sound studies should partition data by patient and report non-acoustic comparators.